But they can help you reach a better weight baseline
In addition to effectively lowering blood sugar and assisting with weight loss, semaglutide has been shown to reduce the risk of cardiovascular disease in people with and without Type 2 diabetes
Five clinical trials in type 2-diabetic subjects (SURPASS 15) have shown that tirzepatide at 515 mg per week reduces both HbA 1c (1.24 to 2.58%) and body weight (5.411.7 kg) by amounts unprecedented for a single agent
Understanding what to expectand whenhelps you and your healthcare provider assess treatment response and make informed decisions about continuing or adjusting therapy
Dehydration Is More Likely Both tirzepatide and alcohol can contribute to: dehydration headaches electrolyte imbalance This is why drinking water in between alcoholic beverages is so important
In simple terms: Ozempic and Wegovy are both semaglutide, but theyre marketed, prescribed, and labeled for different health goals most commonly type 2 diabetes management versus weight management and that impacts how providers select the right option for each patient
.webp)
